These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 19474652

  • 1. The safety of candidate vaginal microbicides since nonoxynol-9: a systematic review of published studies.
    Poynten IM, Millwood IY, Falster MO, Law MG, Andresen DN, Van Damme L, Kaldor JM.
    AIDS; 2009 Jun 19; 23(10):1245-54. PubMed ID: 19474652
    [Abstract] [Full Text] [Related]

  • 2. The evolving design and methods for trials evaluating the safety of candidate vaginal microbicides: a systematic review.
    Jespers V, Millwood IY, Poynten IM, Van Damme L, Kaldor JM.
    Sex Transm Dis; 2013 Sep 19; 40(9):729-36. PubMed ID: 23945427
    [Abstract] [Full Text] [Related]

  • 3. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.
    Roddy RE, Zekeng L, Ryan KA, Tamoufé U, Weir SS, Wong EL.
    N Engl J Med; 1998 Aug 20; 339(8):504-10. PubMed ID: 9709043
    [Abstract] [Full Text] [Related]

  • 4. Phase I safety & preliminary acceptability of nonoxynol-9 vaginal pessary as a vaginal microbicide in low risk women in Pune, India.
    Joshi S, Joglekar N, Ghate M, Unni J, Risbud A, Bentley M, Shepherd M, Bollinger R, Mehendale S.
    Indian J Med Res; 2003 Apr 20; 117():152-7. PubMed ID: 14604303
    [Abstract] [Full Text] [Related]

  • 5. Microbicide research and development--where to?
    Rustomjee R, Abdool Karim Q.
    HIV Clin Trials; 2001 Apr 20; 2(3):185-92. PubMed ID: 11590526
    [Abstract] [Full Text] [Related]

  • 6. Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis.
    Obiero J, Mwethera PG, Hussey GD, Wiysonge CS.
    BMC Infect Dis; 2012 Nov 06; 12():289. PubMed ID: 23130761
    [Abstract] [Full Text] [Related]

  • 7. Nonoxynol-9 for preventing vaginal acquisition of sexually transmitted infections by women from men.
    Wilkinson D, Ramjee G, Tholandi M, Rutherford G.
    Cochrane Database Syst Rev; 2002 Nov 06; (4):CD003939. PubMed ID: 12519623
    [Abstract] [Full Text] [Related]

  • 8. Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects.
    Stafford MK, Ward H, Flanagan A, Rosenstein IJ, Taylor-Robinson D, Smith JR, Weber J, Kitchen VS.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr 01; 17(4):327-31. PubMed ID: 9525433
    [Abstract] [Full Text] [Related]

  • 9. Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: systematic review and meta-analysis of randomised controlled trials including more than 5000 women.
    Wilkinson D, Tholandi M, Ramjee G, Rutherford GW.
    Lancet Infect Dis; 2002 Oct 01; 2(10):613-7. PubMed ID: 12383611
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of vaginal microbicides in preventing HIV transmission.
    Musekiwa A, Fernando NB, Abariga SA.
    Trop Med Int Health; 2020 Jul 01; 25(7):790-802. PubMed ID: 32306503
    [Abstract] [Full Text] [Related]

  • 11. Phase 1 trial of nonoxynol-9 film among sex workers in South Africa.
    Rustomjee R, Abdool Karim Q, Abdool Karim SS, Laga M, Stein Z.
    AIDS; 1999 Aug 20; 13(12):1511-5. PubMed ID: 10465075
    [Abstract] [Full Text] [Related]

  • 12. Recommendations for the development of vaginal microbicides. International Working Group on Vaginal Microbicides.
    AIDS; 1996 Jul 20; 10(8):1-6. PubMed ID: 8828760
    [Abstract] [Full Text] [Related]

  • 13. Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workers. COL-1492 Phase II Study Group.
    Van Damme L, Chandeying V, Ramjee G, Rees H, Sirivongrangson P, Laga M, Perriëns J.
    AIDS; 2000 Jan 07; 14(1):85-8. PubMed ID: 10714571
    [Abstract] [Full Text] [Related]

  • 14. Council calls for guidance on spermicide use.
    AIDS Alert; 1996 Mar 07; 11(3):27-30. PubMed ID: 11363240
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of a low-dose nonoxynol-9 gel for the prevention of sexually transmitted diseases: a randomized clinical trial.
    Richardson BA, Lavreys L, Martin HL, Stevens CE, Ngugi E, Mandaliya K, Bwayo J, Ndinya-Achola J, Kreiss JK.
    Sex Transm Dis; 2001 Jul 07; 28(7):394-400. PubMed ID: 11460023
    [Abstract] [Full Text] [Related]

  • 16. Prioritizing prevention of HIV and sexually transmitted infections: first-generation vaginal microbicides.
    Madan RP, Keller MJ, Herold BC.
    Curr Opin Infect Dis; 2006 Feb 07; 19(1):49-54. PubMed ID: 16374218
    [Abstract] [Full Text] [Related]

  • 17. Colposcopy: still useful in microbicide safety trials?
    Mauck CK, Weiner DH, Lai JJ, Schwartz JL.
    Sex Transm Dis; 2012 Jun 07; 39(6):465-9. PubMed ID: 22592833
    [Abstract] [Full Text] [Related]

  • 18. Increased COX-2 expression in human vaginal epithelial cells exposed to nonoxynol-9, a vaginal contraceptive microbicide that failed to protect women from HIV-1 infection.
    Zalenskaya IA, Cerocchi OG, Joseph T, Donaghay MA, Schriver SD, Doncel GF.
    Am J Reprod Immunol; 2011 Jun 07; 65(6):569-77. PubMed ID: 21241401
    [Abstract] [Full Text] [Related]

  • 19. A comprehensive murine model to evaluate topical vaginal microbicides: mucosal inflammation and susceptibility to genital herpes as surrogate markers of safety.
    Galen BT, Martin AP, Hazrati E, Garin A, Guzman E, Wilson SS, Porter DD, Lira SA, Keller MJ, Herold BC.
    J Infect Dis; 2007 May 01; 195(9):1332-9. PubMed ID: 17397004
    [Abstract] [Full Text] [Related]

  • 20. Twice-daily application of HIV microbicides alter the vaginal microbiota.
    Ravel J, Gajer P, Fu L, Mauck CK, Koenig SS, Sakamoto J, Motsinger-Reif AA, Doncel GF, Zeichner SL.
    mBio; 2012 Dec 18; 3(6):. PubMed ID: 23249810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.